BioCentury
ARTICLE | Company News

TNI BioTech cancer, inflammation, infectious news

May 12, 2014 7:00 AM UTC

TNI will spin out its wholly owned subsidiary Cytocom Inc. to operate TNI's drug development business. The newco will initially focus on developing TNI's immunotherapy products IRT-103, which is low-d...